Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Tolerability of Rosiglitazone Added to Metformin vs Metformin Monotherapy in Type 2 Diabetes
NCT00501020Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2001
- Primary completion
- Feb 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Jun 2001; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00501020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501020.